Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.
Bimekizumab is an investigational humanized monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F.
Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Actemra (tocilizumab) is an interleukin-6 receptor antagonist.
The issue appears to be related to the availability of generic oseltamivir.
The bivalent formulations contain the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
